-
What To Make Of The Viacom-DISH Network Expiration
Wednesday, April 20, 2016 - 1:20pm | 646Read More...Unlike previously believed, the programming agreement between Viacom, Inc. (NASDAQ: VIAB) and DISH Network Corp (NASDAQ: DISH) expires Wednesday at midnight. While Viacom's website states the deal is seven years old with an initial expiration date for January 2016, analysts at BTIG were under the...
-
BTIG Downgrades Brinker, Sees Sales Challenges Likely Remaining
Wednesday, April 20, 2016 - 11:25am | 330Read More...BTIG has downgraded Brinker International, Inc. (NYSE: EAT) to Neutral from Buy, saying that Chili's sales challenges could continue for the next several quarters. Brinker's third quarter adjusted EPS of $1 beat the consensus estimate of $0.98, but the $824.6 million revenue fell short...
-
Despite Weaker Industry Trends, BTIG Is Still Buying Brinker
Monday, April 18, 2016 - 1:12pm | 266Read More...BTIG maintains its Buy rating and $57 price target on Brinker International, Inc. (NYSE: EAT) despite cutting its same store sales estimate for Chili's due to weak industry trends. Dallas, Texas-based Brinker operates casual dining restaurants under the Chili's Grill & Bar brand name and...
-
Apple's Target Cut To $130 By BTIG, Sees 4% Decline In Revenue
Thursday, April 7, 2016 - 9:20am | 327Read More...Apple Inc. (NASDAQ: AAPL) is scheduled to report its quarterly earnings on April 25. BTIG’s Walter Piecyk maintained a Buy rating for the company, while reducing the price target from $141 to $130. The analyst said that Apple’s return to revenue growth could be delayed till fiscal...
-
Shire Just Took Another Step Forward With Its ADHD Drug
Monday, April 4, 2016 - 5:05pm | 287Read More...BTIG's Timothy Chiang said Shire PLC (ADR) (NASDAQ: SHPG) moved one step closer to satisfying the FDA's request for clinical data with its SHP465 (a three-bead formulation of mixed amphetamine salts) compound for the treatment of ADHD (Attention-Deficit Hyperactivity Disorder). The...
-
BTIG: Medivation Acquirer Could Pay 20-30% Premium And Still Buy At Low Valuation
Monday, April 4, 2016 - 10:50am | 248Read More...Media reports suggest Medivation Inc (NASDAQ: MDVN) has hired an investment bank to look into acquisition interest from other companies, while it has no plans to sell itself. BTIG’s Hartaj Singh said that the latest media reports had resulted in “frenzied speculation” of...
-
Square Shrugs Off BTIG Downgrade, Flirts With All-Time High
Thursday, March 31, 2016 - 10:57am | 99Read More...Square Inc (NYSE: SQ) shares are trading lower by $0.35 at $14.67 in Thursday's session. Before the open, BTIG downgraded the issue from Buy to Neutral and removed the price target of $15, since it was reached in Wednesday's session. After a lower open, it challenged its all-time closing high of $...
-
BTIG Downgrades Square, Waiting For A Pullback
Thursday, March 31, 2016 - 9:12am | 268Read More...Shares of Square Inc (NYSE: SQ) have surged more than 40 percent since the beginning of March. BTIG’s Mark Palmer downgraded the rating for the company from Buy to Neutral, and removed the price target of $15, saying that shares had already reached the price target. Analyst Mark Palmer...
-
Verizon's Super Bowl Investment Can Tell Telecom Investors A Lot About The Future Of Small Cell Technology
Friday, March 25, 2016 - 1:58pm | 269Read More...In a new report, BTIG analyst Walter Piecyk takes a look at Verizon Communications Inc. (NYSE: VZ)’s Super Bowl ad for indications of the technological direction that Verizon will be taking in coming years. According to Piecyk, Verizon’s primary talking point of late has been small...
-
BTIG: Buy Teva On Weakness, U.S. Lawmakers Have Little Appetite For Direct Government Negotiation Of Drug Prices
Monday, March 21, 2016 - 8:56am | 272Read More...BTIG's Timothy Chiang maintained a Buy rating on Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA), with a $77 price target. Buy The Weakness Although the stock has declined 17 percent year-to-date, it has outperformed specialty pharma sector as a whole, which is down 34 percent....
-
BTIG: Buy Barracuda, It's Turning Around
Friday, March 18, 2016 - 11:12am | 290Read More...Barracuda Networks Inc (NYSE: CUDA) has received a vote of confidence from BTIG analysts Joel Fishbein, Edward Parker and Abhinav Kapur. Citing an "accelerated shift in the SMB market towards virtual/public cloud deployments," the analysts are upgrading Barracuda to Buy with an attached price...
-
BTIG Steps To The Sidelines On GreenDot
Friday, March 18, 2016 - 9:50am | 231Read More...BTIG’s Mark Palmer downgraded the rating for Green Dot Corporation (NYSE: GDOT) from Buy to Neutral, after the company’s shares surged 25 percent in one month and reached the prior price target of $23. Although Green Dot has significant trapped earnings power, the same is unlikely...
-
BTIG Downgrades First Data To Neutral
Monday, March 7, 2016 - 1:20pm | 324Read More...BTIG has downgraded First Data Corp (NYSE: FDC) to Neutral from Buy on valuation, sending its stock down 5 percent. The brokerage also removed the price target of $13 following the achievement of that level. "We believe FDC's shares are now fairly valued following a strong rebound from...
-
BTIG Recommends 'Beaten Down' Drug Manufacturers Like Teva
Monday, March 7, 2016 - 11:31am | 336Read More...BTIG’s Timothy Chiang mentioned that shares of specialty pharmaceutical companies are down 20 percent year-to-date, as compared to a 5.8 percent decline in the S&P 500. The decline is largely attributable to investor concerns surrounding the sustainability of earnings growth and the...
-
Wall Street Loves Texas Roadhouse After Q4 Earnings
Tuesday, February 23, 2016 - 5:40pm | 554Read More...Shares of Texas Roadhouse Inc (NASDAQ: TXRH) surged more than 12 percent Tuesday after it reported an upbeat earnings for the fourth quarter. The restaurant operator earned $0.32 for the fourth quarter, and the number topped Street view by $0.02. Comparable sales increased 4.5 percent at...





